resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

resTORbio (TORC) Prices 7.2M Shares Common Offering at $6.95/ShMarch 20, 2019 5:59 AM resTORbio, Inc. Announces Proposed Public Offering of Common StockMarch 18, 2019 4:16 PM